GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Asset Turnover

Hisamitsu Pharmaceutical Co (TSE:4530) Asset Turnover : 0.11 (As of Nov. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Hisamitsu Pharmaceutical Co's Revenue for the three months ended in Nov. 2023 was 円35,850 Mil. Hisamitsu Pharmaceutical Co's Total Assets for the quarter that ended in Nov. 2023 was 円339,605 Mil. Therefore, Hisamitsu Pharmaceutical Co's Asset Turnover for the quarter that ended in Nov. 2023 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. Hisamitsu Pharmaceutical Co's annualized ROE % for the quarter that ended in Nov. 2023 was 5.45%. It is also linked to ROA % through Du Pont Formula. Hisamitsu Pharmaceutical Co's annualized ROA % for the quarter that ended in Nov. 2023 was 4.35%.


Hisamitsu Pharmaceutical Co Asset Turnover Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Asset Turnover Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.38 0.40 0.42 0.44

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 0.11 0.11 0.12

Competitive Comparison of Hisamitsu Pharmaceutical Co's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Asset Turnover falls into.



Hisamitsu Pharmaceutical Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Hisamitsu Pharmaceutical Co's Asset Turnover for the fiscal year that ended in Feb. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Feb. 2024 )/( (Total Assets (A: Feb. 2023 )+Total Assets (A: Feb. 2024 ))/ count )
=141706/( (313917+328779)/ 2 )
=141706/321348
=0.44

Hisamitsu Pharmaceutical Co's Asset Turnover for the quarter that ended in Nov. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Nov. 2023 )/( (Total Assets (Q: Aug. 2023 )+Total Assets (Q: Nov. 2023 ))/ count )
=35850/( (344300+334909)/ 2 )
=35850/339604.5
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Hisamitsu Pharmaceutical Co  (TSE:4530) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Hisamitsu Pharmaceutical Co's annulized ROE % for the quarter that ended in Nov. 2023 is

ROE %**(Q: Nov. 2023 )
=Net Income/Total Stockholders Equity
=14772/270944.5
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(14772 / 143400)*(143400 / 339604.5)*(339604.5/ 270944.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=10.3 %*0.4223*1.2534
=ROA %*Equity Multiplier
=4.35 %*1.2534
=5.45 %

Note: The Net Income data used here is four times the quarterly (Nov. 2023) net income data. The Revenue data used here is four times the quarterly (Nov. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Hisamitsu Pharmaceutical Co's annulized ROA % for the quarter that ended in Nov. 2023 is

ROA %(Q: Nov. 2023 )
=Net Income/Total Assets
=14772/339604.5
=(Net Income / Revenue)*(Revenue / Total Assets)
=(14772 / 143400)*(143400 / 339604.5)
=Net Margin %*Asset Turnover
=10.3 %*0.4223
=4.35 %

Note: The Net Income data used here is four times the quarterly (Nov. 2023) net income data. The Revenue data used here is four times the quarterly (Nov. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Hisamitsu Pharmaceutical Co Asset Turnover Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines